SCHEDULE: Morgan Stanley Divests XOMA Royalty Corp Stake
Ownership Filing (Schedule 13G Amendment)
Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have reported a complete divestment of their beneficial ownership in XOMA Royalty Corp, holding 0.0% of the class of securities.
Summary
- Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed a Schedule 13G, Amendment No. 4, indicating they no longer beneficially own any shares of XOMA Royalty Corp's common stock.
- As of July 31, 2026, both entities report 0.00 shares owned, representing 0% of the class of securities.
- This filing signifies a complete cessation of beneficial ownership for both Morgan Stanley and Morgan Stanley Investment Management Inc. in XOMA Royalty Corp.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a negative sentiment due to the complete divestment of shares, indicating a lack of confidence or strategic shift away from the company.
Negatives
- Morgan Stanley and its subsidiary have completely divested their holdings in XOMA Royalty Corp, now owning 0% of the common stock.
- This indicates a complete lack of investment or strategic interest from a major financial institution.
Risks
- The complete divestment by Morgan Stanley and its subsidiary could signal a negative outlook on XOMA Royalty Corp's future performance or strategic direction, potentially impacting investor confidence.
Future Outlook
The filing itself does not contain forward-looking statements or guidance from XOMA Royalty Corp. The information pertains to the ownership status of Morgan Stanley.
Management Comments
- "As of the date hereof, Morgan Stanley has ceased to be the beneficial owner of more than five percent of the class of securities."
- "As of the date hereof, Morgan Stanley Investment Management Inc. has ceased to be the beneficial owner of more than five percent of the class of securities."
- "The securities being reported on by Morgan Stanley as a parent holding company are owned, or may be deemed to be beneficially owned, by Morgan Stanley Investment Management Inc., a wholly-owned subsidiary of Morgan Stanley."
Industry Context
StockSavvy.ai notes that a complete divestment by a major financial institution like Morgan Stanley from a royalty company can sometimes precede significant strategic shifts or indicate a reassessment of the company's long-term value proposition within the broader life sciences or technology sectors.
Stakeholder Impact
- Shareholders of XOMA Royalty Corp may view the complete divestment by Morgan Stanley as a negative signal, potentially impacting market sentiment and share price.
Next Steps
- Morgan Stanley and Morgan Stanley Investment Management Inc. will no longer be required to file Schedule 13G amendments for XOMA Royalty Corp unless their beneficial ownership changes significantly again.
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Date of Event Which Requires Filing of this Statement (Cessation of beneficial ownership) |
| 2026-08-07 | Date of Signatures on Schedule 13G and Joint Filing Agreement |
Recommendation
holdThe filing indicates a complete divestment by Morgan Stanley, which is a negative signal. However, without further information on XOMA Royalty Corp's performance or outlook, a 'hold' recommendation is prudent, advising investors to monitor the company's subsequent disclosures and strategic actions.
Keywords
XOMA Royalty Corp, Morgan Stanley, Schedule 13G, Divestment, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.